[Indications for the use of somatostatin and octreotide in digestive pathology].
The authors report their experience about the use of somatostatin (SST-14) (47 cases) and its analog octreotide (15 cases) in gastrointestinal diseases. On the basis of own clinical data and literature review, at present they think useful SST-14 employ in the upper gastrointestinal tract bleeding and acute pancreatitis. Out of the emergency, they consider favourable the use of octreotide, above all because of the easy subcutaneous administration's route.
Zan
S
S
Cattedra di Chirurgia Generale, Università degli Studi, Torino.
Roy
L
L
Zanon
C
C
Mobiglia
A
A
Mussa
B
B
Raviola
P
P
Mormile
C
C
Ballario
R
R
Giustetto
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004066:Digestive System Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D004630:Emergencies; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D013004:Somatostatin / Q000008:administration & dosage*; D013997:Time Factors
D005765:Gastrointestinal Agents; D013004:Somatostatin; D015282:Octreotide
Indicazioni all'uso della somatostatina e dell'octreotide in patologia digestiva.